Venus Remedies to sell patented product Elores to Cipla for Indian Territory

18 Oct 2019 Evaluate

Venus Remedies has entered into agreement to sell its patented product Elores to Cipla for the Indian Territory. This association with Cipla will enable greater patient access of Elores in India. Elores is a novel combination of Ceftriaxone. Sulbactam and Disodium EDTA indicated for the treatment of life-threatening infections caused by gram-negative bacteria.

The present deal with Cipla for Indian Territory will enable VRL to focus its efforts on strengthening its global position for Elores. Currently, Elores is available in 7 countries and is scheduled to be launched in another 4 territories over the next 12 months; it is under registration in many other parts of world.

Venus Remedies is a pharmaceutical manufacturing company. The company is engaged in manufacturing products catering to various segments such as Oncology, Cephalosporins, Carbapenems and Other Specialties.

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×